The New Mexico Department of Justice (NMDOJ) is urging residents to proceed with caution when obtaining medications for weight loss, especially the class of treatments commonly referred to as GLP-1 medications (such as branded products like Ozempic, Wegovy, Mounjaro, Zepbound and similar).
These medications are increasingly being advertised by med spas, wellness clinics, online sellers and social-media vendors — but not all of the products offered are legitimate or safe. Some sellers may be offering unapproved or compounded versions of GLP-1 drugs, which have not been evaluated by the U.S. Food & Drug Administration (FDA) for safety, effectiveness or quality.